Deal●
AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs
- AstraZeneca plans to invest $2 billion in Summit Therapeutics
- The companies plan to ramp up their collaboration on cancer drugs
NSE close · Mon, 28 SeptNifty 5022,780.25▼ 1.56%Nifty Bank54,471.65▼ 1.99%Midcap 10059,914.20▼ 1.63%Smallcap 25017,863.20▼ 1.63%India VIX13.64▲ 12.17%IT28,086.50▼ 0.26%Auto26,525.05▼ 1.64%Pharma26,761.65▼ 0.89%FMCG45,264.35▼ 1.47%Metal12,854.40▼ 1.78%Realty850.90▼ 2.12%Energy36,693.20▼ 2.00%PSU Bank8,026.10▼ 3.24%Financials24,671.65▼ 1.69%Media1,539.25▼ 0.74%Defence9,231.20▼ 1.81%Durables38,162.90▼ 0.30%Biggest movesRSYSTEMS▲ 16.8%REPRO▲ 15.8%DAMCAPITAL▲ 14.8%SMCGLOBAL▲ 13.6%BPLPHARMA▲ 13.3%PRIMO▲ 11.3%SSDL▲ 11.2%SYNCOMF▲ 10.7%
●
AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination
- AstraZeneca filed a US FDA application for HUTCHMED’s lung cancer drug combination